ArticleClinical kidney journal2019

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study.

Jan Menne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.